Prot #CURLu177PSM0001: A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date1/26/23 → 1/26/26

Funding

  • Cato Research Ltd. (Prot #CURLu177PSM0001)
  • Curium US LLC (Prot #CURLu177PSM0001)